03/31/2011 - 10:01am

Patients diagnosed with high blood-glucose levels that cannot control the condition over time likely will develop such eye-related complications as retinopathy 10 years later, according to a report in the February issue of Archives of Ophthalmology.

03/31/2011 - 9:17am

Patients that have been handling their diabetes for a long time are less likely to experience complications, according to a new study conducted by Joslin Diabetes Center researchers.

03/30/2011 - 8:22am

A biopharmaceutical company that specializes in diabetes treatments has appointed a new board chairman.

03/28/2011 - 3:34pm

The Diabetes Research Institute Foundation on Wednesday announced that the first-ever Walk with Walgreens Family Fun Day & Health Fair will take place April 10 at 14 locations across Florida.

03/28/2011 - 1:43pm

A study published online in the journal Diabetes Care, and slated for the April print issue, suggested that counting carbohydrates could lead to an improvement in quality of life and a reduction in body mass index and waist circumference in patients with Type 1 diabetes who receive continuous subcutaneous insulin infusions.

03/28/2011 - 12:23pm

The American Pharmacists Association Foundation announced Monday the selection of 25 companies, community health departments and other organizations — collectively known as “communities” — that will take part in the foundation’s initiative to improve care for people disproportionately affected by diabetes across the United States.

03/25/2011 - 12:45pm

A drug for Type 2 diabetes made by Takeda Pharmaceutical taken in the morning prevented the disease from developing in nearly three-quarters of patients who were at risk, according to a new study in the New England Journal of Medicine.

03/24/2011 - 11:26am

Novo Nordisk said new data showed that its basal insulin analog is just as effective as human basal insulin in Type 1 diabetes patients ages 2 to 5 years.

03/23/2011 - 6:11am

The American Association of Clinical Endocrinologists has teamed up with drug maker Takeda to develop an online resource that will be reviewed and evaluated by top medical experts.